PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Manulife Financial Corp (MFC-PM.TO)
23.680.18 (-0.75%)
23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.84%
Negative revenue growth while Insurance - Life median is 0.00%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-11.84%
Negative gross profit growth while Insurance - Life median is -5.28%. Seth Klarman would suspect poor product pricing or inefficient production.
-1.89%
Negative EBIT growth while Insurance - Life median is -0.94%. Seth Klarman would check if external or internal factors caused the decline.
-1.89%
Negative operating income growth while Insurance - Life median is -0.94%. Seth Klarman would check if structural or cyclical issues are at play.
-8.88%
Negative net income growth while Insurance - Life median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-8.89%
Negative EPS growth while Insurance - Life median is -4.63%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-8.90%
Negative diluted EPS growth while Insurance - Life median is -5.43%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-75.63%
Negative OCF growth while Insurance - Life median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-75.63%
Negative FCF growth while Insurance - Life median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
143.50%
10Y revenue/share CAGR 1.25-1.5x Insurance - Life median of 104.42%. Mohnish Pabrai would see if consistent reinvestment or product expansions drive this gap.
114.58%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 53.12%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
105.82%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 32.39%. Joel Greenblatt might see a short-term competitive advantage at play.
No Data
No Data available this quarter, please select a different quarter.
409.11%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 43.67%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
481.11%
3Y OCF/share growth > 1.5x Insurance - Life median of 0.24%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
379.99%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 246.30% over a decade. Joel Greenblatt might see a standout compounder of earnings.
194.75%
5Y net income/share CAGR > 1.5x Insurance - Life median of 119.17%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
131.20%
3Y net income/share CAGR > 1.5x Insurance - Life median of 44.70%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
No Data
No Data available this quarter, please select a different quarter.
189.97%
5Y equity/share CAGR > 1.5x Insurance - Life median of 52.92%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
179.77%
3Y equity/share CAGR > 1.5x Insurance - Life median of 15.40%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.80%
Asset growth exceeding 1.5x Insurance - Life median of 1.18%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
6.00%
BV/share growth exceeding 1.5x Insurance - Life median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
-3.26%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.